↓ Skip to main content

Dipeptidyl Aminopeptidases

Overview of attention for book
Cover of 'Dipeptidyl Aminopeptidases'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Peptide Substrates of Dipeptidyl Peptidases
  3. Altmetric Badge
    Chapter 2 Phosphorus-Containing Inhibitors of Proteolytic Enzymes
  4. Altmetric Badge
    Chapter 3 Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8.
  5. Altmetric Badge
    Chapter 4 Prediction of Dipeptidyl Peptidase (DP) 8 Structure by Homology Modelling
  6. Altmetric Badge
    Chapter 5 Dipeptidyl Aminopeptidases
  7. Altmetric Badge
    Chapter 6 Expression and Function of Dipeptidyl Peptidase IV and Related Enzymes in Cancer
  8. Altmetric Badge
    Chapter 7 DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis.
  9. Altmetric Badge
    Chapter 8 In Vivo Effects of a Potent, Selective Dppii Inhibitor
  10. Altmetric Badge
    Chapter 9 Expression of Dipeptidyl Peptidase IV-Like Enzymes in Human Peripheral Blood Mononuclear Cells
  11. Altmetric Badge
    Chapter 10 Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
  12. Altmetric Badge
    Chapter 11 Prolyl Endopeptidase Cleaves the Apoptosis Rescue Peptide Humanin and Exhibits an Unknown Post-Cysteine Cleavage Specificity
  13. Altmetric Badge
    Chapter 12 Distribution of Dipeptidyl Peptidase Iv-Like Activity Enzymes in Canine and Porcine Tissue Sections by RT-PCR
  14. Altmetric Badge
    Chapter 13 Relative Contribution of Incretins to the Glucose Lowering Effect of DP IV Inhibitors in Type 2 Diabetes Mellitus (T2DM)
  15. Altmetric Badge
    Chapter 14 Dipeptidyl Peptidase IV: A Molecular Switch of Vascular Actions of Neuropeptide Y
  16. Altmetric Badge
    Chapter 15 Dipeptidylpeptidase IV (DPIV) and Alanyl-Aminopeptidases (AAPs) as a New Target Complex for Treatment of Autoimmune and Inflammatory Diseases—Proof of Concept in a Mouse Model of Colitis
  17. Altmetric Badge
    Chapter 16 Dipeptidyl Aminopeptidases
  18. Altmetric Badge
    Chapter 17 Possible Role of DP IV Inhibitors in Acne Therapy
  19. Altmetric Badge
    Chapter 18 Dipeptidyl Peptidase-IV Activity and/or Structure Homologs (DASH): Contributing Factors in the Pathogenesis of Rheumatic Diseases?
  20. Altmetric Badge
    Chapter 19 Dipeptidyl Peptidase IV (DP IV, CD26) and Aminopeptidase N (APN, CD13) as Regulators of T Cell Function and Targets of Immunotherapy in CNS Inflammation
  21. Altmetric Badge
    Chapter 20 CD26/DP IV in T Cell Activation and Autoimmunity
  22. Altmetric Badge
    Chapter 21 DPIV/CD26 and FAP in Cancer: A Tale of Contradictions
  23. Altmetric Badge
    Chapter 22 Type-II Transmembrane Prolyl Dipeptidases and Matrix Metalloproteinases in Membrane Vesicles of Active Endothelial Cells
  24. Altmetric Badge
    Chapter 23 Dipeptidyl Aminopeptidases
  25. Altmetric Badge
    Chapter 24 Role of Neuropeptide Y and Dipeptidyl Peptidase IV in Regulation of Ewing’s Sarcoma Growth
  26. Altmetric Badge
    Chapter 25 The Role of CD26/DPP IV in Preservation of Early Pulmonary Graft Function
Attention for Chapter 3: Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8.
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

wikipedia
4 Wikipedia pages

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8.
Chapter number 3
Book title
Dipeptidyl Aminopeptidases
Published in
Advances in experimental medicine and biology, January 2006
DOI 10.1007/0-387-32824-6_3
Pubmed ID
Book ISBNs
978-0-387-29058-4, 978-0-387-32824-9
Authors

Xin Chen, Chen, Xin

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 14%
Researcher 3 14%
Student > Bachelor 3 14%
Student > Doctoral Student 2 9%
Professor > Associate Professor 2 9%
Other 5 23%
Unknown 4 18%
Readers by discipline Count As %
Medicine and Dentistry 7 32%
Biochemistry, Genetics and Molecular Biology 4 18%
Agricultural and Biological Sciences 4 18%
Immunology and Microbiology 1 5%
Business, Management and Accounting 1 5%
Other 0 0%
Unknown 5 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2016.
All research outputs
#7,453,479
of 22,786,691 outputs
Outputs from Advances in experimental medicine and biology
#1,226
of 4,933 outputs
Outputs of similar age
#40,085
of 154,379 outputs
Outputs of similar age from Advances in experimental medicine and biology
#12
of 40 outputs
Altmetric has tracked 22,786,691 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,933 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,379 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.